Erlotinib Sandoz

Erlotinib Sandoz is an oral medication used to treat certain types of cancer. This pharmaceutical is designed to target specific proteins involved in cancer cell growth.

Erlotinib Sandoz is primarily used in the treatment of non-small cell lung cancer and pancreatic cancer. It works by inhibiting the growth and spread of cancer cells. This medication is often prescribed for patients who have specific genetic markers that make them suitable candidates for this treatment.

Common effects of Erlotinib Sandoz may include skin rash, diarrhea, and fatigue. Some patients may also experience loss of appetite and nausea. These effects can vary in severity and may require monitoring by a healthcare professional.

Erlotinib Sandoz should be handled with care and stored as directed. It is important to follow the prescribed dosage and administration instructions. Patients should inform their healthcare provider about any pre-existing conditions or allergies before starting this medication.

Erlotinib Sandoz may interact with certain medications, including those that affect liver enzymes. It is advisable to avoid alcohol while taking this medication. Patients should consult their healthcare provider about potential interactions with other medications they are taking.